A Phase 1, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, Parallel-Group, Single and Multiple-Dose Study of Desvenlafaxine in Korean Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 31 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History